Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.36 +10.17%
on 04/06/18
93.89 -3.35%
on 03/19/18
-2.83 (-3.02%)
since 03/16/18
3-Month
82.36 +10.17%
on 04/06/18
97.98 -7.39%
on 01/29/18
+2.85 (+3.24%)
since 01/18/18
52-Week
66.66 +36.12%
on 05/31/17
97.98 -7.39%
on 01/29/18
+22.89 (+33.74%)
since 04/18/17

Most Recent Stories

More News
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 32.48 (-1.43%)
CNCR : 27.24 (-1.23%)
IBB : 107.35 (+0.07%)
PSCH : 117.67 (+0.44%)
XBI : 90.74 (-0.42%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 32.48 (-1.43%)
CNCR : 27.24 (-1.23%)
IBB : 107.35 (+0.07%)
PSCH : 117.67 (+0.44%)
XBI : 90.74 (-0.42%)
Strong Week Despite Weak Finish

Strong Week Despite Weak Finish

YY : 95.75 (+0.44%)
CPA : 123.40 (+1.71%)
INTT : 7.25 (-0.68%)
SNE : 50.46 (+1.39%)
XBI : 90.74 (-0.42%)
AMZN : 1,527.84 (+1.60%)
Is PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) a Hot ETF Right Now?

Smart Beta ETF report for PBE

PBE : 49.73 (+0.12%)
ILMN : 250.00 (+0.61%)
IBB : 107.35 (+0.07%)
VRTX : 163.36 (-0.99%)
REGN : 321.39 (-0.38%)
XBI : 90.74 (-0.42%)
4 Sector ETFs That Crushed S&P 500 in 9-Year Bull Run

These sector ETFs emerged winners in the nine-year bull market.

RYH : 182.77 (+0.46%)
FDN : 126.67 (+0.19%)
XLY : 104.37 (+0.47%)
VCR : 163.43 (+0.52%)
PSJ : 73.04 (+0.26%)
PJP : 63.34 (+0.24%)
QTEC : 78.24 (-0.48%)
FXH : 71.43 (+0.85%)
FBT : 137.47 (-0.07%)
SOXX : 182.16 (-0.98%)
SPY : 270.39 (+0.07%)
XBI : 90.74 (-0.42%)
4 Sector ETFs That Crushed S&P 500 in 9-Year Bull Run

These sector ETFs emerged winners in the nine-year bull market.

RYH : 182.77 (+0.46%)
FDN : 126.67 (+0.19%)
XLY : 104.37 (+0.47%)
VCR : 163.43 (+0.52%)
PSJ : 73.04 (+0.26%)
PJP : 63.34 (+0.24%)
QTEC : 78.24 (-0.48%)
FXH : 71.43 (+0.85%)
FBT : 137.47 (-0.07%)
SOXX : 182.16 (-0.98%)
SPY : 270.39 (+0.07%)
XBI : 90.74 (-0.42%)
Here’s How You Know You’ve Found a Great Trade…

This post Here’s How You Know You’ve Found a Great Trade… appeared first on Daily Reckoning . Market pundits fight the tape. Today, Greg Guenthner looks under the hood of this market to tell...

XBI : 90.74 (-0.42%)
Biotech ETFs Head to Head: XBI vs. IBB.

Head-to-head comparison of two Biotech ETFs, XBI and IBB.

CELG : 91.01 (-0.10%)
ARRY : 15.29 (-1.29%)
IBB : 107.35 (+0.07%)
BIVV : 104.98 (+0.32%)
GILD : 75.68 (+0.28%)
AMGN : 175.11 (+0.13%)
XBI : 90.74 (-0.42%)
JUNO : 86.96 (+0.10%)
Biotech ETFs Head to Head: XBI vs. IBB.

Head-to-head comparison of two Biotech ETFs, XBI and IBB.

CELG : 91.01 (-0.10%)
ARRY : 15.29 (-1.29%)
IBB : 107.35 (+0.07%)
BIVV : 104.98 (+0.32%)
GILD : 75.68 (+0.28%)
AMGN : 175.11 (+0.13%)
XBI : 90.74 (-0.42%)
JUNO : 86.96 (+0.10%)
The Only Safe Way to Buy the Dip

This post The Only Safe Way to Buy the Dip appeared first on Daily Reckoning . Buying the dip is suddenly back in fashion again just one week after stocks ripped off their lows. Today, Greg Guenthner...

XBI : 90.74 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 92.41
1st Resistance Point 91.57
Last Price 90.74
1st Support Level 90.23
2nd Support Level 89.73

See More

52-Week High 97.98
Last Price 90.74
Fibonacci 61.8% 86.02
Fibonacci 50% 82.32
Fibonacci 38.2% 78.62
52-Week Low 66.66

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar